Vis enkel innførsel

Employing fasting plasma glucose to safely limit the use of oral glucose tolerance tests in pregnancy: a pooled analysis of four Norwegian studies

dc.contributor.authorRai, Anam Shakil
dc.contributor.authorSletner, Line
dc.contributor.authorJenum, Anne Karen
dc.contributor.authorØverby, Nina Cecilie
dc.contributor.authorStafne, Signe Nilssen
dc.contributor.authorQvigstad, Elisabeth
dc.contributor.authorPripp, Are Hugo
dc.contributor.authorSagedal, Linda Reme
dc.date.accessioned2024-02-21T13:34:43Z
dc.date.available2024-02-21T13:34:43Z
dc.date.created2024-01-02T12:20:40Z
dc.date.issued2023
dc.identifier.citationRai, A. S., Sletner, L., Jenum, A. K., Øverby, N. C., Stafne, S. N., Qvigstad, E., Pripp, A. H. & Sagedal, L. R. (2023). Employing fasting plasma glucose to safely limit the use of oral glucose tolerance tests in pregnancy: a pooled analysis of four Norwegian studies. Frontiers in Endocrinology, 14, 1-10. doi:en_US
dc.identifier.issn1664-2392
dc.identifier.urihttps://hdl.handle.net/11250/3119073
dc.language.isoengen_US
dc.publisherFrontiers Media S.A.en_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleEmploying fasting plasma glucose to safely limit the use of oral glucose tolerance tests in pregnancy: a pooled analysis of four Norwegian studiesen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.rights.holder© 2023 The Author(s)en_US
dc.subject.nsiVDP::Medisinske Fag: 700en_US
dc.source.pagenumber10en_US
dc.source.volume14en_US
dc.source.journalFrontiers in Endocrinologyen_US
dc.identifier.doi10.3389/fendo.2023.1278523
dc.identifier.cristin2218856
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail
Filnavn:
Article.pdf
Størrelse:
464.6Kb
Format:
PDF
Åpne

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal